{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T16:10:19Z","timestamp":1723219819325},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Indwelling pleural catheters (IPCs) reduce dyspnea and improve quality of life in patients with malignant pleural effusions (MPEs). Data on outcomes of MPEs secondary to metastatic melanoma managed with IPCs are scarce. We aimed to evaluate outcomes of patients receiving IPCs for MPEs secondary to melanoma compared with other malignancies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We identified patients from our prospectively collected database of all patients who had an IPC insertion for MPEs at our tertiary care center for melanoma between May 2006 and November 2018 and for nonmelanoma between May 2006 and June 2013. Chart reviews were conducted to obtain patient demographics, catheter complications, time of IPC removal or death, x-ray imaging, and pleural fluid characteristics.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>We identified 27 MPEs because of melanoma and 1114 because of nonmelanoma malignancies treated with IPC. The most frequent complication was pleural fluid loculation requiring fibrinolytics which was significantly higher in the melanoma (14.8%) compared with the nonmelanoma group (3.8%; <jats:italic toggle=\"yes\">P<\/jats:italic>=0.02). Cumulative incidence functions for catheter removal (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.8) or death with catheter in situ (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.3) were not significant between melanoma and nonmelanoma groups in competing risk analysis. Baseline radiographic pleural effusion scores were similar, but became significantly higher (increased pleural opacity) in the melanoma group at time points following IPC insertion (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.05).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>MPEs because of melanoma had a higher rate of loculations requiring fibrinolytics and less radiographic improvement after IPC insertion suggesting this patient subgroup has a more complicated pleural space which may be less responsive to drainage.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/lbr.0000000000000877","type":"journal-article","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T15:00:11Z","timestamp":1658502011000},"page":"244-251","update-policy":"http:\/\/dx.doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Outcomes for Malignant Pleural Effusions Because of Melanoma Treated With Indwelling Pleural Catheters"],"prefix":"10.1097","volume":"30","author":[{"given":"Pourya","family":"Masoudian","sequence":"first","affiliation":[{"name":"Division of Respirology, Department of Medicine, University of Ottawa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chanel","family":"Kwok","sequence":"additional","affiliation":[{"name":"Division of Respirology, Department of Medicine, University of Ottawa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pen","family":"Li","sequence":"additional","affiliation":[{"name":"Division of Respirology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Hosseini","sequence":"additional","affiliation":[{"name":"Division of Respirology, Department of Medicine, University of Ottawa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tinghua","family":"Zhang","sequence":"additional","affiliation":[{"name":"Ottawa Methods Centre, The Ottawa Hospital Research Institute, Ottawa, Ontario"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayvan","family":"Amjadi","sequence":"additional","affiliation":[{"name":"Division of Respirology, Department of Medicine, University of Ottawa"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,7]]},"reference":[{"key":"R1-20240809","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0002-9343(77)90154-1","article-title":"Carcinomatous involvement of the pleura: an analysis of 96 patients","volume":"63","author":"Chernow","year":"1977","journal-title":"Am J Med"},{"key":"R2-20240809","doi-asserted-by":"crossref","first-page":"ii32","DOI":"10.1136\/thx.2010.136994","article-title":"Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010","volume":"65","author":"Roberts","year":"2010","journal-title":"Thorax"},{"key":"R3-20240809","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1164\/rccm.201807-1415ST","article-title":"Management of malignant pleural effusions. an official ATS\/STS\/STR Clinical Practice Guideline","volume":"198","author":"Feller-Kopman","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"R4-20240809","doi-asserted-by":"crossref","first-page":"1800349","DOI":"10.1183\/13993003.00349-2018","article-title":"ERS\/EACTS statement on the management of malignant pleural effusions","volume":"52","author":"Bibby","year":"2018","journal-title":"Eur Respir J"},{"key":"R5-20240809","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1001\/jama.2012.5535","article-title":"Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial","volume":"307","author":"Davies","year":"2012","journal-title":"JAMA"},{"key":"R6-20240809","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jama.2017.17426","article-title":"Effect of an indwelling pleural catheter vs talc pleurodesis on hospitalization days in patients with malignant pleural effusion: The AMPLE Randomized Clinical Trial","volume":"318","author":"Thomas","year":"2017","journal-title":"JAMA"},{"key":"R7-20240809","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1002\/(SICI)1097-0142(19991115)86:10<1992::AID-CNCR16>3.0.CO;2-M","article-title":"A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions","volume":"86","author":"Putnam","year":"1999","journal-title":"Cancer"},{"key":"R8-20240809","doi-asserted-by":"crossref","first-page":"E235","DOI":"10.9778\/cmajo.20170163","article-title":"Clinical predictors of successful and earlier pleurodesis with a tunnelled pleural catheter in malignant pleural effusion: a cohort study","volume":"6","author":"Li","year":"2018","journal-title":"CMAJ Open"},{"key":"R9-20240809","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1164\/rccm.201607-1404OC","article-title":"Randomized trial of pleural fluid drainage frequency in patients with malignant pleural effusions. The ASAP Trial","volume":"195","author":"Wahidi","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"R10-20240809","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21551","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"R12-20240809","doi-asserted-by":"crossref","first-page":"647684","DOI":"10.1155\/2012\/647684","article-title":"Metastatic behavior in melanoma: timing, pattern, survival, and influencing factors","volume":"2012","author":"Tas","year":"2012","journal-title":"J Oncol"},{"key":"R13-20240809","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/1097-0142(197908)44:2<776::AID-CNCR2820440252>3.0.CO;2-T","article-title":"The thorax as the initial site for systemic relapse in malignant melanoma: a prospective survey of 324 patients","volume":"44","author":"Gromet","year":"1979","journal-title":"Cancer"},{"key":"R14-20240809","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2214\/ajr.137.2.293","article-title":"Metastatic melanoma in the thorax: report of 130 patients","volume":"137","author":"Chen","year":"1981","journal-title":"AJR Am J Roentgenol"},{"key":"R15-20240809","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3322\/canjclin.30.3.137","article-title":"Malignant melanoma: pattern of metastasis","volume":"30","author":"Lee","year":"1980","journal-title":"CA Cancer J Clin"},{"key":"R16-20240809","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1378\/chest.71.2.176","article-title":"Thoracic metastasis in malignant melanoma. A radiographic survey of 65 patients","volume":"71","author":"Webb","year":"1977","journal-title":"Chest"},{"key":"R17-20240809","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1016\/j.athoracsur.2020.09.088","article-title":"Pleural melanoma metastasis","volume":"112","author":"D\u2019Ambrosio","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"R18-20240809","doi-asserted-by":"crossref","first-page":"641.e1","DOI":"10.1016\/j.amjmed.2012.11.017","article-title":"Black pleural effusion","volume":"126","author":"Saraya","year":"2013","journal-title":"Am J Med"},{"key":"R19-20240809","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/dc.24370","article-title":"Pleural metastasis from auricular melanoma: a brief report","volume":"48","author":"Straccia","year":"2020","journal-title":"Diagn Cytopathol"},{"key":"R20-20240809","doi-asserted-by":"crossref","first-page":"E314","DOI":"10.1503\/cmaj.091312","article-title":"Black pleural effusion in melanoma","volume":"182","author":"Liao","year":"2010","journal-title":"CMAJ"},{"key":"R21-20240809","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ejso.2008.06.009","article-title":"Long-term indwelling pleural catheter (PleurX) for malignant pleural effusion unsuitable for talc pleurodesis","volume":"35","author":"Sioris","year":"2009","journal-title":"Eur J Surg Oncol"},{"key":"R22-20240809","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1136\/thoraxjnl-2014-205285","article-title":"Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score","volume":"69","author":"Clive","year":"2014","journal-title":"Thorax"},{"key":"R23-20240809","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1183\/16000617.0019-2016","article-title":"Malignant pleural effusion: from bench to bedside","volume":"25","author":"Psallidas","year":"2016","journal-title":"Eur Respir Rev"},{"key":"R24-20240809","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1183\/09031936.03.00403902","article-title":"Immunological mechanisms in pleural disease","volume":"21","author":"Antony","year":"2003","journal-title":"Eur Respir J"},{"key":"R25-20240809","first-page":"217","article-title":"Lower proliferation rate in metastatic effusion mesothelial cells than in benign effusions","volume":"29","author":"Rehnberg","year":"2007","journal-title":"Anal Quant Cytol Histol"},{"key":"R26-20240809","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/sj.bjc.6601635","article-title":"Tumour-induced apoptosis in human mesothelial cells: a mechanism of peritoneal invasion by Fas Ligand\/Fas interaction","volume":"90","author":"Heath","year":"2004","journal-title":"Br J Cancer"},{"key":"R27-20240809","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1378\/chest.95.2.320","article-title":"Survival time of patients with pleural metastatic carcinoma predicted by glucose and pH studies","volume":"95","author":"Rodriguez-Panadero","year":"1989","journal-title":"Chest"},{"key":"R29-20240809","first-page":"186","article-title":"Malignant pleural effusions: appropriate treatment approaches","volume":"41","author":"Aydin","year":"2009","journal-title":"Eurasian J Med"},{"key":"R30-20240809","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00408-012-9445-1","article-title":"Management of malignant pleural effusion","volume":"191","author":"Kastelik","year":"2013","journal-title":"Lung"},{"key":"R31-20240809","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000430907","article-title":"Black pleural effusion: a unique presentation of metastatic melanoma","volume":"8","author":"Chhabra","year":"2015","journal-title":"Case Rep Oncol"},{"key":"R32-20240809","doi-asserted-by":"crossref","first-page":"e00490","DOI":"10.1002\/rcr2.490","article-title":"Black pleural effusion: an unusual presentation of metastatic melanoma diagnosed by medical thoracoscopy","volume":"7","author":"Sumalani","year":"2019","journal-title":"Respirol Case Rep"},{"key":"R33-20240809","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s12055-018-0756-6","article-title":"Black pleural effusion: etiology, diagnosis, and treatment","volume":"35","author":"Kamal","year":"2019","journal-title":"Indian J Thorac Cardiovasc Surg"},{"key":"R34-20240809","first-page":"000416","article-title":"Black urine and black pleural fluid: a distinctive presentation of metastatic melanoma","volume":"3","author":"Mishe\u2019el","year":"2016","journal-title":"Eur J Case Rep Intern Med"},{"key":"R35-20240809","doi-asserted-by":"crossref","first-page":"469","DOI":"10.5144\/0256-4947.2017.469","article-title":"Recurrence of malignant melanoma presenting as black-colored pyopneumothorax: a rare entity","volume":"37","author":"Patel","year":"2017","journal-title":"Ann Saudi Med"},{"key":"R36-20240809","doi-asserted-by":"crossref","first-page":"96","DOI":"10.4103\/0970-2113.63615","article-title":"Unusual thoracic manifestation of metastatic malignant melanoma","volume":"27","author":"Mohan","year":"2010","journal-title":"Lung India"},{"key":"R37-20240809","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s10147-004-0427-z","article-title":"Malignant melanoma of pleura in a patient with giant congenital \u201cbathing suit\u201d hairy nevus","volume":"9","author":"Mohanty","year":"2004","journal-title":"Int J Clin Oncol"},{"key":"R38-20240809","first-page":"138","article-title":"Malignant melanoma presenting as an isolated pleural effusion","volume":"75","author":"Shameem","year":"2011","journal-title":"Monaldi Arch Chest Dis"},{"key":"R39-20240809","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.3892\/ol.2015.3104","article-title":"Primary malignant melanoma of the pleura with rapid progression: a case report and literature review","volume":"9","author":"Wang","year":"2015","journal-title":"Oncol Lett"},{"key":"R40-20240809","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.2169\/internalmedicine.3111-19","article-title":"Primary pleural melanoma: a case report and literature review","volume":"58","author":"Murakami","year":"2019","journal-title":"Intern Med"}],"container-title":["Journal of Bronchology &amp; Interventional Pulmonology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/LBR.0000000000000877","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T15:29:25Z","timestamp":1723217365000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/LBR.0000000000000877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,25]]},"references-count":38,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/lbr.0000000000000877","relation":{},"ISSN":["1948-8270"],"issn-type":[{"type":"electronic","value":"1948-8270"}],"subject":[],"published":{"date-parts":[[2022,7,25]]},"assertion":[{"value":"2021-11-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}